EUA
Clear Dx SARS-CoV-2 Test
FDA Emergency Use Authorization · Clear Labs, Inc. · Mar 24, 2022
Key facts
| Product | Clear Dx SARS-CoV-2 Test |
|---|---|
| Company | Clear Labs, Inc. |
| Product type | RT-PCR and Sequencing, Multiple Targets |
| Date | Mar 24, 2022 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: